Dravet Syndrome Adjunctive Treatment Study

I'm Interested!

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet Syndrome

Sex at Birth: Any
Age: Child (Birth - 17), Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase III
Conditions Being Studied: Epilepsy

Study Purpose

The purpose of this study is to assess the safety (symptoms and medical problems you may experience –known as side effects) and efficacy (how well and for how long the study drug treated) of the study drug on subjects who have Dravet syndrome.

Who Can Participate

Age: 2 years and older

Principal Investigator
Jennifer Waldron DO

Department/Division
Pediatrics (Neurology)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: STUDY20210262
StudyID: 2021-0530
ClinicalTrials.gov: NCT04572243

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422